Clinical trial of personalized therapy based on genetic alteration for patients with resectable colorectal oligometastases

ABSTRACT: Primary outcome(s): Proportion of BRAF V600E mutation and pre-treatment ctDNA detection in patients with resectable colorectal oligometastases

DISEASE(S): Colorectal Oligometastases

PROVIDER: 2657160 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR